Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
210M
-
Number of holders
-
193
-
Total 13F shares, excl. options
-
103M
-
Shares change
-
-1.44M
-
Total reported value, excl. options
-
$1.48B
-
Value change
-
-$24.1M
-
Put/Call ratio
-
0.62
-
Number of buys
-
90
-
Number of sells
-
-92
-
Price
-
$14.37
Significant Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) as of Q3 2021
242 filings reported holding BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share as of Q3 2021.
BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) has 193 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 103M shares
of 210M outstanding shares and own 49.27% of the company stock.
Largest 10 shareholders include BlackRock Inc. (15.3M shares), BAKER BROS. ADVISORS LP (12.7M shares), VANGUARD GROUP INC (9.38M shares), STATE STREET CORP (7.11M shares), Sarissa Capital Management LP (3.93M shares), HealthCor Management, L.P. (3.85M shares), GEODE CAPITAL MANAGEMENT, LLC (3.14M shares), Fisher Asset Management, LLC (3.01M shares), Artisan Partners Limited Partnership (2.85M shares), and NORTHERN TRUST CORP (2.44M shares).
This table shows the top 193 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.